Furthermore, Kaplan–Meier survival analysis revealed that low expression of miR-99a/miR-100 and high expression of AKT1 are associated with poorer survival rate of BC patients (Figs. 3j, l and S3C). The gene discussed is AKT1; the disease is breast cancer.